777 related articles for article (PubMed ID: 37516898)
1. Drugs for anxiety disorders.
Med Lett Drugs Ther; 2023 Aug; 65(1682):121-128. PubMed ID: 37516898
[No Abstract] [Full Text] [Related]
2. Drugs for anxiety disorders.
Med Lett Drugs Ther; 2019 Aug; 61(1578):121-126. PubMed ID: 31386647
[No Abstract] [Full Text] [Related]
3. Drugs for depressionr.
Med Lett Drugs Ther; 2023 Dec; 65(1691):193-200. PubMed ID: 38133585
[No Abstract] [Full Text] [Related]
4. Drugs for Depression.
Med Lett Drugs Ther; 2020 Feb; 62(1592):25-32. PubMed ID: 32320387
[No Abstract] [Full Text] [Related]
5. Drugs for chronic insomnia.
Med Lett Drugs Ther; 2023 Jan; 65(1667):1-6. PubMed ID: 36630579
[No Abstract] [Full Text] [Related]
6. Nonopioid drugs for pain.
Med Lett Drugs Ther; 2022 Mar; 64(1645):33-40. PubMed ID: 35231019
[No Abstract] [Full Text] [Related]
7. Drugs for chronic insomnia.
Med Lett Drugs Ther; 2018 Dec; 60(1562):201-205. PubMed ID: 30625122
[No Abstract] [Full Text] [Related]
8. In Brief: New benzodiazepine warnings.
Med Lett Drugs Ther; 2020 Nov; 62(1610):175. PubMed ID: 33429404
[No Abstract] [Full Text] [Related]
9. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
10. Drugs for menopausal symptoms.
Med Lett Drugs Ther; 2020 Aug; 62(1604):124-128. PubMed ID: 32960867
[No Abstract] [Full Text] [Related]
11. Drugs for menopausal symptoms.
Med Lett Drugs Ther; 2024 Mar; 66(1697):33-38. PubMed ID: 38412276
[No Abstract] [Full Text] [Related]
12. Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Scheinfeld N
Dermatol Online J; 2013 Nov; 19(11):20616. PubMed ID: 24314785
[TBL] [Abstract][Full Text] [Related]
13. Application of antidepressants in depression: A systematic review and meta-analysis.
Yuan Z; Chen Z; Xue M; Zhang J; Leng L
J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
[TBL] [Abstract][Full Text] [Related]
14. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
Hidalgo RB; Tupler LA; Davidson JR
J Psychopharmacol; 2007 Nov; 21(8):864-72. PubMed ID: 17984162
[TBL] [Abstract][Full Text] [Related]
15. Table: Safety of drugs for IBS in pregnancy and lactation (online only).
Med Lett Drugs Ther; 2020 Mar; 62(1594):e48-e49. PubMed ID: 32324174
[No Abstract] [Full Text] [Related]
16. Review of the side-effect profile of buspirone.
Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
[TBL] [Abstract][Full Text] [Related]
17. Understanding the pharmacokinetics of anxiolytic drugs.
Altamura AC; Moliterno D; Paletta S; Maffini M; Mauri MC; Bareggi S
Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):423-40. PubMed ID: 23330992
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of social anxiety disorder: what does the evidence tell us?
Davidson JR
J Clin Psychiatry; 2006; 67 Suppl 12():20-6. PubMed ID: 17092192
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
